Mr. Hem says biotech stocks have been volatile this
year with some seeing double-digit percentage increases in the number of their
shares sold short.
He points to three stocks in particular, including one that saw its short
interest surge 66%.
Read more Benzinga.com
small-cap articles: http://www.benzinga.com/news/small-cap
Disclaimer: This article was posted with the permission
of a third-party contributor and the opinions contained therein do not
necessarily reflect those of Smallcappower. Smallcappower does not endorse
any investment advice provided by these third-party contributors. Please
consult your investment advisor before making any investment
decisions.
Ubika Corporation and its divisions Smallcappower, Ubika
Communication and Ubika Research are not registered with any financial or
securities regulatory authority in Ontario or Canada, and do not provide
nor claims to provide investment advice or recommendations to any visitor of
this site or readers of any content on this site. – See more at: http://www.smallcappower.com/pages/small-cap-power-disclosure
